BioCryst Pharmaceuticals | BCRX - القيمة السوقية





القيمة السوقية تغيير تاريخ
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Chugai Pharma JPY 14.46T 617.89B 2026-03
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
DBV Technologies USD 274M 17M 2025-09
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
Neurocrine Biosciences USD 13.34B 800M 2026-05
Novavax USD 1.09B 316M 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05